Metabolic effects and biotransformation of perfluorohexyloctane in human hepatocytes
Environment International · 2026
DOI: 10.1016/j.envint.2026.110112 ↗Kurz gefasst
Fachartikel in der Zeitschrift Environment International, 2026. Verfasst von Andi Alijagic und 7 weiteren Autor:innen. Beteiligte Einrichtung: Man-Technology-Environment (MTM) Research Centre, School of Science and Technology, Örebro University, SE-701 82 Örebro, Sweden; Inflammatory Respons…. Hauptthemen laut MEDLINE: Fluorocarbons, Hepatocytes, Environmental Pollutants. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Vetenskapsrådet, Svenska Forskningsrådet Formas, HORIZON EUROPE Framework Programme.
Abstract (Originalsprache)
• Perfluorohexyloctane (F6H8) induces broad metabolic reprogramming in HepaRG cells. • Metabolomics data revealed non-monotonic, concentration-dependent effects. • F6H8 exposure altered amino acid, lipid, and central carbon metabolism. • A putative biotransformation product, perfluorohexyloctanoic acid, was detected. • Findings suggest metabolic persistence and PFAS-like behavior of F6H8. Perfluorohexyloctane (F6H8) is a semifluorinated alkane recently approved for ophthalmic treatment of dry eye disease. Although considered locally safe for topical use, its structural similarity to persistent per- and polyfluoroalkyl substances (PFAS) raises concerns about systemic accumulation and long-term toxicity. To investigate potential hepatic effects, we examined the metabolic impact of F6H8 exposure in human HepaRG hepatocytes across a broad concentration range representing short- and long-term exposure scenarios. Combined targeted and untargeted metabolic profiling by ultra-high-performance liquid chromatography–quadrupole time-of-flight mass spectrometry (UHPLC-QTOFMS) was performed on intracellular extracts and extracellular media. F6H8 induced pronounced, concentration-dependent metabolic alterations, many of which exhibited non-monotonic responses. Low concentrations primarily affected amino acid, fatty acid, and lipid metabolism, while central carbon metabolism was disrupted only at the highest exposures. Notably, a putative biotransformation product, perfluorohexyloctanoic acid, was detected, suggesting metabolic persistence and conversion to a PFAS-like structure. This metabolite showed strong associations with cellular metabolic profiles and elicited metabolic changes that only partially overlapped with those induced by the parent compound, indicating distinct biological activity following biotransformation. These findings indicate that F6H8 elicits broad metabolic reprogramming and may not be metabolically inert as previously assumed. Given its clinical use and structural similarity to persistent fluorochemicals, the results highlight the need for comprehensive, long-term safety assessment of F6H8 and related semifluorinated alkanes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Man-Technology-Environment (MTM) Research Centre, School of Science and Technology, Örebro University, SE-701 82 Örebro, Sweden; Inflammatory Response and Infection Susceptibility Centre (iRiSC), Örebro University, Öreb…
- Man-Technology-Environment (MTM) Research Centre, School of Science and Technology, Örebro University, SE-701 82 Örebro, Sweden.
- Turku Centre for Biotechnology, University of Turku and Åbo Akademi University, FI-20520 Turku, Finland; Department of Chemistry, University of Turku FI-20500 Turku, Finland.
- School of Medical Sciences, Faculty of Medicine and Health, Örebro University, SE-701 82 Örebro, Sweden; Turku Centre for Biotechnology, University of Turku and Åbo Akademi University, FI-20520 Turku, Finland; Departmen…
- Man-Technology-Environment (MTM) Research Centre, School of Science and Technology, Örebro University, SE-701 82 Örebro, Sweden. Electronic address: tuulia.hyotylainen@oru.se.
Förderung
- Vetenskapsrådet
- Svenska Forskningsrådet Formas
- HORIZON EUROPE Framework Programme
- Stiftelsen för Kunskaps- och Kompetensutveckling
- Novo Nordisk Fonden
Zitieren
APA
Alijagic, A., Chaker, J., Barbosa, J. M. G., Duberg, D., Castro-Alves, V., Dickens, A. M., Orešič, M., & Hyötyläinen, T. (2026). Metabolic effects and biotransformation of perfluorohexyloctane in human hepatocytes. Environment International. https://doi.org/10.1016/j.envint.2026.110112
Vancouver
Alijagic A, Chaker J, Barbosa JMG, Duberg D, Castro-Alves V, Dickens AM, et al. Metabolic effects and biotransformation of perfluorohexyloctane in human hepatocytes. Environment International. 2026. doi:10.1016/j.envint.2026.110112
BibTeX
@article{Alijagic2026,
author = {Alijagic, Andi and Chaker, Jade and Barbosa, João Marcos G and Duberg, Daniel and Castro-Alves, Victor and Dickens, Alex M and Orešič, Matej and Hyötyläinen, Tuulia},
title = {Metabolic effects and biotransformation of perfluorohexyloctane in human hepatocytes},
journal = {Environment International},
year = {2026},
doi = {10.1016/j.envint.2026.110112}
}
EUVIMED